Introduction
The central nervous toxicity of "massive" penicillin therapy occurring particularly in patients with compromised renal function is well known (Weinstein et al., 1964 ; Bloomer et al., 1967; Smith et al., 1967) . The purpose of the present report is to call attention to another hazard of "massive" sodium penicillin G therapy, which is not related to renal failure. We have had under observation three patients receiving treatment with 100 mega units of sodium penicillin G daily for subacute bacterial endocarditis who developed moderate to marked hypokalaemia and metabolic alkalosis within 10 to 14 days of therapy. Two of the three patients presented with additional hypernatraemia. Pertinent data are summarized in Table I. The cause of hypernatraemia was apparent. The entire dose of 100 mega units of sodium penicillin G had been administered in 1 litre of 5 % dextrose in water daily in order to prevent pulmonary oedema by fluid overload. It was not appreciated that 100 mega units of penicillin represent a substantial solute load of 170 mEq, or 340 mOsm. When the patients stopped drinking because of apathy and weakness caused by central nervous system toxicity of penicillin, by hypokalaemia, or by cardiac failure, parenteral fluid intake of 1 litre daily did not balance extrarenal and renal fluid losses in the face of additional 340 mOsm. of sodium-penicillin to be excreted by the kidney. Thus hypernatraemia was the logical consequence of negative water balance. Despite inadequate fluid intake leading to hypernatraemia, daily urine volumes exceeded 1 litre owing to the osmotic diuretic action of 100 mega units of penicillin, which is roughly equivalent to 600 ml. of 10% mannitol.
Whereas the development of hypernatraemia was easily explained by available clinical data, the mechanism leading to hypokalaemia and metabolic alkalosis remained obscure. Though anorexia, slight diarrhoea, and diuretics could be discerned as contributing factors, the degree of potassium depletion in our patients and its resistance to correction by oral and parenteral potassium supplements suggested some additional factor, possibly renal potassium losses induced by penicillin. In order to elucidate the mechanism by which penicillin might cause potassium depletion, six additional patients undergoing treatment with 100 mega units of sodium penicillin G daily were studied. We were able to demonstrate that penicillin can induce urinary potassium loss presumably by acting as a nonreabsorbable anion on distal tubular cation transport. 
Methods
Six patients needing high-dosage penicillin therapy were treated with daily infusions of 100 mega units of sodium penicillin G in 2,000 ml. of 5% dextrose in water. They were kept on an ordinary " salt-free " hospital diet, containing 10-30 mEq of sodium chloride daily. Diuretics were withheld. Urine was collected in 24-hour periods. Serum electrolytes and arterial pH were determined every three to four days. Sodium, potassium, and chloride in serum and urine, and serum urea and creatinine were determined by Technicon AutoAnalyzer, arterial pH by glass electrode, and arterial CO. content by gas chromatography (Beckmann).
Results
The clinical features of the six patients studied are presented in Table II (Black and Milne, 1952 ; Blahd and Bassett, 1953 ;  Squires and Huth, 1959) . In our patients, by contrast, urinary potassium excretion did not drop below 50-70 mEq/24 hours despite frank hypokalaemia. Thus it appears safe to conclude that renal potassium losses constituted the main cause of hypokalaemia. Poor intake of food and consequently deficient potassium intake was a contributing factor to potassium depletion in some but not in all patients. Other known causes for increased urinary potassium, such as diuretics, corticosteroid therapy, or renal tubular acidosis, were absent.
A logical explanation for the potassium-wasting effect of penicillin emerges from its physicochemical properties. Penicillin G is a highly water-soluble organic acid with a molecular weight of 334. Its molecular size is slightly greater than that of mannitol, which implies low permeability through renal tubular walls. Furthermore, penicillin is a rather strong organic acid with a pK value of 2.76 at 250C. This means that even in maximally acidic urine over 90% will be ionized, (Clapp et al., 1962) . Hypokalaemia should secondarily augment hydrogen ion excretion by stimulating ammonia production (Seldin et al., 1954) as well as sustain metabolic alkalosis by increasing bicarbonate reabsorption in the proximal tubule (Rector et al., 1964) . The importance of chloride depletion causing increased hydrogen ion excretion (Gulyassy et al., 1962) (Schwartz et al., 1955) with mild secondary aldosteronism due to clinically apparent or inapparent heart failure or inadequate food intake, form the necessary background for penicillin to cause potassium depletion.
Since patients with subacute bacterial endocarditis often present with heart failure and receive digitalis, it is mandatory to prevent potassium depletion as well as sodium loads. This is easily achieved by substituting the potassium salt of penicillin for the sodium salt. Unfortunately it is more and more difficult to get potassium penicillin G for medical use. The reason for this is probably a largely unjustified fear of inducing potassium intoxication in patients with renal failure. The only instance of fatal potassium intoxication which we were able to find reported in the literature occurred immediately after an obviously too " rapid intravenous administration " of 20 mega units of potassium penicillin G (Thomson, 1964) . In the event of renal failure "massive" therapy with potassium penicillin G must be reduced in order to avoid both the central nervous system toxicity of high serum levels of penicillin and the hyperkalaemia. If potassium penicillin G is not available, potassium depletion and sodium overload may be prevented by combining sodium penicillin with potassium-sparing diuretics like aldactone, triamterene, or amiloride. These drugs block the exchange of sodium for potassium in the distal tubule (Baer et al., 1966; Liddle, 1966) . Consequently the non-reabsorbable anion penicillin is forced to appear in the urine together with the cation sodium and cannot cause or aggravate either congestive heart failure or hypokalaemia.
Introduction
Cushing's syndrome, unless due to corticosteroid therapy, is the result of increased cortisol secretion from either an adrenocortical tumour or bilateral adrenocortical hyperplasia. On the basis of bioassay data it appears that circulating A.C.T.H. is undetectable in the plasma of patients with Cushing's syndrome associated with an adrenal adenoma or carcinoma, whereas patients with bilateral adrenal hyperplasia have high normal or raised values (Clayton, 1958; Williams et al., 1961; Vance et al., 1962 ; Ney et al., 1963; Davies, 1964 ; Nelson and Sprunt, 1965 ; Retiene et al., 1965 ; Nelson et al., 1966) . The determination of plasma A.C.T.H. levels is therefore of value in differentiating between the various causes of Cushing's syndrome.
Despite their specificity, bioassays for A.C.T.H. are technically complex and time-consuming and require large volumes of blood to obtain accurate results. The recent introduction of radioimmunoassays for this hormone (Yalow et al., 1964; Demura et al., 1966; Landon and Greenwood, 1968; Orth et al., 1968) enables circulating levels to be determined more simply by using between 1 and 10 ml. of plasma. Large numbers of subjects can be studied, with serial determinations
